The development of effective synthetic pathways is critical in many industrial sectors. The growing adoption of flow chemistry has opened new opportunities for more cost-effective and environmentally
The DeepDrugDiscovery platform utilized a carefully curated library of 1.16 million compounds sourced from established commercial databases. This strategic selection of commercial sources ensures most
Flavonoids represent a potential source of new antitrypanosomatidic leads. Starting from a library of natural products, we combined target-based screening on pteridine reductase 1 with phenotypic scre
